We are live on ! Find out more
FEED

ENVUE MEDICAL INC NEW
FEED

Delisted

FEED was delisted on the 15th of September, 2026.

8 hedge funds and large institutions have $251K invested in ENVUE MEDICAL INC NEW in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

54% more capital invested

Capital invested by funds: $163K → $251K (+$88.2K)

33% more funds holding

Funds holding: 68 (+2)

6.39% more ownership

Funds ownership: 8.39%14.78% (+6.4%)

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

FEED Hedge Fund Activity: Q3 2024 in Review

8 of the 6,979 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q3 2024, worth a combined $251K — up 54% from $163K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new FEED positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, adding an estimated $93.4K. The largest seller was Geode Capital Management, cutting an estimated $873.

  • 8 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q3 2024, up from 6 in Q2 2024.
  • Funds reported $251K of ENVUE MEDICAL INC NEW stock for Q3 2024, up 54% quarter-over-quarter.
  • 2 funds opened new ENVUE MEDICAL INC NEW positions in Q3 2024 and 0 closed out, a net change of +2 holders.
  • The largest ENVUE MEDICAL INC NEW buyer in Q3 2024 was Armistice Capital, an estimated $93.4K added.
  • The largest ENVUE MEDICAL INC NEW seller in Q3 2024 was Geode Capital Management, an estimated $873 sold.

Based on aggregated 13F filings for Q3 2024.